학술논문
Infliximab abrogates adenine-induced chronic kidney disease via modulation of the MAPK/JNK/ASK signaling pathway in rats
Document Type
Article
Author
Source
In: Naunyn-Schmiedeberg's Archives of Pharmacology . (Naunyn-Schmiedeberg's Archives of Pharmacology, January 2024, 397(1):207-219)
Subject
Language
English
ISSN
14321912
00281298
00281298